Persona of Central Serous Chorioretinopathy (CSCR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02819622|
Recruitment Status : Completed
First Posted : June 30, 2016
Last Update Posted : June 30, 2016
Purpose: Central serous retinopathy (CSCR) is characterized by macular detachment due to thickened choroid mostly affecting young men under perceived stress. While most previous studies in CSCR have been retrospective and have focused on a single facet of the patient's personality, the investigators conducted a prospective intercontinental controlled study to analyze the multifaceted personality profile in CSCR.
Design: Prospective interview. Participants and Controls: Subjects with CSCR consented to participate in a questionnaire. Controls not having retinal disease were recruited from the same clinic.
Main Outcome Measures: The main parameters registered were presence of stress, daily number of cups caffeine intake, personality traits (Type A; obsessive-compulsive; aggressive).
Methods: The interview consisted of a 60-item questionnaire. Recruitment of participants was from January 2015 to February 2016. Controls were matched for age, gender and race. Statistical analyses were done using univariate and multivariate analysis.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||83 participants|
|Official Title:||Persona of Central Serous Chorioretinopathy|
|Study Start Date :||January 2015|
|Actual Primary Completion Date :||February 2016|
|Actual Study Completion Date :||February 2016|
control (no disease)
central serous retinopathy group
Central serous retinopathy (with CSCR disease) by exam and OCT
- personality type [ Time Frame: through study completion, an average of 1 year ]one interview by the ophthalmologist himself
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02819622
|Rafic Hariri University Hospital|
|Beirut, South Beirut, Lebanon, 1136044|
|Principal Investigator:||ahmad mansour, md||RHUH|